Is Tyra Biosciences Inc (TYRA) overvalued? · $531.8M cap
Tyra Biosciences Inc (TYRA) is a biotechnology company listed on US.
This page asks whether Tyra Biosciences Inc (TYRA) looks expensive on cached numbers — not a short thesis.
No cached income statement for TYRA, so there is no earnings base to call rich or cheap.
TYRA currently screens at market cap $531.8M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next TYRA 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the TYRA stock page for the full model, not this heading.
Not investment advice.